Free Trial
→ I'm handing you this one free (From Behind the Markets) (Ad)tc pixel
NASDAQ:FBIOP

Fortress Biotech Earnings Date & Estimates

Fortress Biotech logo
$15.17 -0.28 (-1.84%)
As of 02:15 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Fortress Biotech is estimated to report earnings on Monday, November 16, 2026, before market opens.

Research:Profile

Upcoming Earnings Announcement

Announcement Date
Time
Before Market Opens
Google Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab)

What Analysts Expect from Fortress Biotech

Fortress Biotech is expected to post earnings of -$0.27 per share on revenue of $21.58 million.

Consensus Estimates

Consensus EPS
-$0.27
Expected Revenue
$21.58 million

Recent Track Record

Last Reported
Q2 2023
Last Quarter EPS
-$0.07
Last Quarter Revenue
$17.39 million

Prepare for the Earnings Call

Fortress Biotech Earnings FAQ

Fortress Biotech (NASDAQ:FBIOP) is estimated to report earnings on Monday, November 16, 2026, before market opens. This date is estimated from past reporting schedules and may change once the company confirms it.

Analysts expect Fortress Biotech to post earnings of -$0.27 per share for the quarter.

The consensus revenue estimate for Fortress Biotech is $21.58 million for the quarter.

Fortress Biotech Earnings Headlines

Fortress Biotech (FBIOP) Expected to Release Earnings on Monday
November 9 at 4:27 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31188411
Fortress Biotech, Inc. - Preferred stock price target increased by 10.97% to $44.09
October 23, 2026  |  msn.comhttps://www.msn.com/en-us/news/other/fortress-biotech-inc-preferred-stock-price-target-increased-by-1097-to-4409/ar-AA2fUbHB
I'm handing you this one free
Elon Musk doesn't own the chip powering every Tesla, every Starlink dish, and every AI satellite he builds. He licenses it from one overlooked company. That supplier just got a major catalyst. Musk filed to launch 1,000,000 satellites, a move analyst Dylan believes could drive a 100X bigger bill for this chipmaker starting December 8th.tc pixel
November 10 at 1:00 AM  |  Behind the Markets (Ad)
Fortress Biotech, Inc. - Preferred stock price target increased by 10.56% to $37.34
September 15, 2026  |  msn.comhttps://www.msn.com/en-us/money/top-stocks/fortress-biotech-inc-preferred-stock-price-target-increased-by-10-56-to-37-34/ar-AA2ciU8l
Fortress Biotech to Present at the H.C. Wainwright 28th Annual Global Investment Conference
September 8, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/08/3357555/28889/en/fortress-biotech-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference.html
Fortress Biotech Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
August 13, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/13/3344925/28889/en/fortress-biotech-reports-second-quarter-2026-financial-results-and-recent-corporate-highlights.html
See More Fortress Biotech Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Fortress Biotech? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Fortress Biotech and other key companies, straight to your email.

About Fortress Biotech

Fortress Biotech (NASDAQ:FBIOP) is a U.S.-based biopharmaceutical company that acquires, develops and commercializes prescription medicines. Its work spans areas including oncology, rare diseases, dermatology and other specialty markets.

The company operates through a network of subsidiary businesses and uses partnerships and licensing arrangements to advance drug candidates and bring therapies to market. Its portfolio includes both development-stage programs and commercial products, with activities conducted primarily in the United States.

Fortress was founded in 2006 as Coronado Biosciences and adopted its current name in 2015. Founder Lindsay A. Rosenwald has served as the company’s chairman and chief executive officer.

View Fortress Biotech Profile
Earnings Tools